About the Event

The government is continuing its strong commitment to building a robust biodefense industry, one with the capability and capacity to meet the nation's needs. For industry participants looking to participate in the government's biodefense efforts, the Biodefense Vaccines and Therapeutics conference is the ideal venue to get the latest and most detailed information on the various agencies' biodefense vaccines and therapeutics requirements and interact face-to-face with the government representatives tasked with building a biodefense capacity.

Past government efforts have focused on rapid development of biodefense vaccines. Recently, the government has moved away from the 'one bug - one drug' philosophy and shifted its strategies and plans towards the rapid development of a portfolio of vaccines, therapeutics and other medical countermeasures capable of combating a whole host of biodefense agents. This 'one drug - many bugs' philosophy is creating new opportunities for industry participation. For companies looking to participate in the national biodefense efforts, accessing these new opportunities require getting the up to date information on the government's latest funding programs and strategic plans.

Biodefense Vaccines and Therapeutics has established itself as the place where government and industry come together to share their strategic plans and discuss industry's participation in the government's biodefense efforts. The conference will once again provide detailed information about the role biotechnology and pharmaceutical companies, research contractors and institutes, and universities can play in addressing the nation's need for biodefense vaccines, therapeutics and other medical countermeasures. The government's senior biodefense experts will be on hand to explain biodefense funding availability, process for accessing funding, and which products at what stages of development the agencies are looking for to meet national demands, all crucial information you'll need to make informed decisions about your participation and involvement. Biodefense leaders from the biotechnology and pharmaceutical industry will provide their perspectives and feedback to the government's plans to accelerate the development of needed countermeasures, strengthen government and industry collaboration, and build a profitable and viable biodefense business sector.

Pre-Conference Symposium

Late Stage Biodefense Vaccines & Therapeutics Development June 4, 2007 * 8:00 a.m. to 5:00 p.m. Chaired by: Michael Callahan, M.D., DTM&H, Program Manager, Defense Science Office, DEFENSE ADVANCED RESEARCH PROJECTS AGENCY Peter Hobart, Ph.D, Science Director, U.S. ARMY MEDICAL RESEARCH INSTITUTE FOR INFECTIOUS DISEASES Michael Kurilla, M.D, Ph.D., Director, Office of BioDefense Research Affairs and Associate Director for BioDefense , NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NIH This pre-conference Symposium will provide a briefing by leading biodefense researchers on late stage biodefense vaccines and therapeutics developments, including developments of antiviral therapeutics, developments in immunomodulators/immunostimulators as potential adjuvants, prophylactics and therapeutics, developments in anthrax and ricin vaccine candidates, and developments in rapid scale up and manufactures of medical countermeasures.

THE NETWORKING FAIR Explore partnership and collaboration opportunities June 4 - 6, 2007 Once again, this year's event will feature the Networking Fair, an ideal opportunity for representatives from government, biotechnology and pharmaceutical companies, research institutions and universities to come together to explore opportunities for partnering and collaboration. Past attendees have found the Fair a great value-add to their conference experience. The Fair will feature: Government "help desks" where conference attendees can ask government representatives about current opportunities to collaborate with the government on the development and production of biodefense vaccines and therapeutics Companies and universities sharing information and showcasing their capabilities

Participating government agencies to date:

Department of Human and Health Services, HHS

National Institue of Health, NIH

DTRA

JSTO-CBD

USAMRMC

DARPA

USAMRIID

Click Here to Download Brochure.